immuno-oncology: what is next for aml?
Published 3 years ago • 56 plays • Length 1:26Download video MP4
Download video MP3
Similar videos
-
2:11
the current role of immuno-oncology in aml and future outlooks
-
1:05
the future of immuno-oncology
-
2:09
eha: aml immuno-oncology updates
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
1:29
the current landscape of immunotherapy for aml: an update from ash 2023
-
2:41
israeli company on the edge of finding diabetes cure
-
4:46
acute myeloid leukemia (aml) treatment options
-
5:09
what do you see as the future of aml treatments? #aml
-
1:45
the role of non-covalent btkis in the era of covalent btkis for b-cell malignancies
-
11:19
immunotherapy for aml & all
-
2:45
safety and efficacy of inotuzumab ozogamicin conditioning for allosct in lymphoid malignancies
-
6:50
an overview of the immunotherapy landscape in aml: antibodies, bispecifics, & car-t
-
2:22
the need for novel agents to treat patients with mcl who have relapsed after targeted therapy
-
1:09
menin inhibitors for the treatment of aml: insights into the covalent-101 trial
-
2:26
insights into the future of aml therapy: the increasing use of targeted agents
-
1:02
the impact of sequencing in aml
-
1:59
assessing if a patient with dlbcl is responding to treatment using pet-ct and novel assays
-
1:30
a phase i trial investigating a novel oral flt3 inhibitor, bmf-500, in flt3-mutant aml
-
4:54
emerging immunotherapies for aml
-
1:21
trends in allosct for good-risk aml: a longitudinal study
-
1:27
incorporating new technologies into the real-life classification of aml to guide treatment decisions
-
1:28
the role of allogeneic transplantation in patients with aml in the frontline setting